Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Smilax china is a medicinal plant widely used in traditional Chinese medicine and Ayurveda. Its rhizomes or roots are valued for their analgesic, anti-inflammatory, diuretic, stimulant, carminative, laxative, and tonic properties. It is used to treat inflammatory disorders such as rheumatoid arthritis and gout; venereal diseases including syphilis; skin conditions like psoriasis; and other ailments such as epilepsy and chronic headaches. The plant contains steroid saponins and flavonoids as its main active compounds. Smilax china demonstrates broad biological activities including anti-inflammatory, antioxidant, anticancer, antibacterial effects[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on smilax china.